390 related articles for article (PubMed ID: 24183073)
1. Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes.
Fenton JI; Hord NG; Ghosh S; Gurzell EA
Prostaglandins Leukot Essent Fatty Acids; 2013; 89(6):379-90. PubMed ID: 24183073
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products.
Fialkow J
Am J Cardiovasc Drugs; 2016 Aug; 16(4):229-239. PubMed ID: 27138439
[TBL] [Abstract][Full Text] [Related]
3. Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health.
Djuricic I; Calder PC
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():383-406. PubMed ID: 36662586
[TBL] [Abstract][Full Text] [Related]
4. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008.
Papanikolaou Y; Brooks J; Reider C; Fulgoni VL
Nutr J; 2014 Apr; 13():31. PubMed ID: 24694001
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA.
Doughman SD; Krupanidhi S; Sanjeevi CB
Curr Diabetes Rev; 2007 Aug; 3(3):198-203. PubMed ID: 18220672
[TBL] [Abstract][Full Text] [Related]
7. Associations of erythrocyte ω-3 fatty acids with biomarkers of ω-3 fatty acids and inflammation in breast tissue.
Roy S; Brasky TM; Belury MA; Krishnan S; Cole RM; Marian C; Yee LD; Llanos AA; Freudenheim JL; Shields PG
Int J Cancer; 2015 Dec; 137(12):2934-46. PubMed ID: 26137879
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acid blood biomarkers increase linearly in men and women after tightly controlled intakes of 0.25, 0.5, and 1 g/d of EPA + DHA.
Patterson AC; Chalil A; Aristizabal Henao JJ; Streit IT; Stark KD
Nutr Res; 2015 Dec; 35(12):1040-51. PubMed ID: 26500082
[TBL] [Abstract][Full Text] [Related]
9. Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition.
Troesch B; Eggersdorfer M; Laviano A; Rolland Y; Smith AD; Warnke I; Weimann A; Calder PC
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32846900
[TBL] [Abstract][Full Text] [Related]
10. Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health Initiative.
Brasky TM; Rodabough RJ; Liu J; Kurta ML; Wise LA; Orchard TS; Cohn DE; Belury MA; White E; Manson JE; Neuhouser ML
Am J Clin Nutr; 2015 Apr; 101(4):824-34. PubMed ID: 25739930
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer.
Alexander DD; Bassett JK; Weed DL; Barrett EC; Watson H; Harris W
Nutr Cancer; 2015; 67(4):543-54. PubMed ID: 25826711
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects.
Pisaniello AD; Psaltis PJ; King PM; Liu G; Gibson RA; Tan JT; Duong M; Nguyen T; Bursill CA; Worthley MI; Nicholls SJ; Di Bartolo BA
Atherosclerosis; 2021 May; 324():27-37. PubMed ID: 33812168
[TBL] [Abstract][Full Text] [Related]
13. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.
Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y
Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469
[TBL] [Abstract][Full Text] [Related]
14. Dietary omega-3 fatty acids for women.
Bourre JM
Biomed Pharmacother; 2007; 61(2-3):105-12. PubMed ID: 17254747
[TBL] [Abstract][Full Text] [Related]
15. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.
Dasilva G; Pazos M; García-Egido E; Gallardo JM; Rodríguez I; Cela R; Medina I
J Nutr Biochem; 2015 Nov; 26(11):1385-92. PubMed ID: 26320676
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids.
Russell FD; Bürgin-Maunder CS
Mar Drugs; 2012 Nov; 10(11):2535-59. PubMed ID: 23203276
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
Harris WS; Dayspring TD; Moran TJ
Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
[TBL] [Abstract][Full Text] [Related]
18. Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas.
Wang IE; Yi S; Block RC; Mousa SA
Nutr Res Rev; 2022 Dec; 35(2):295-307. PubMed ID: 34253265
[TBL] [Abstract][Full Text] [Related]
19. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
20. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
